Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Genetic Technologies Ltd (GENE)

NASDAQ
Currency in USD
Disclaimer
2.190
-0.250(-10.25%)
Real-time Data

GENE Comments

Trading halt on ASX for GTG (the underlying stock of GENE) today - waiting for announcement regardig the Covid-19 risk test.
Trading halt expires 1st of June. Expect a statement from the company before this time.
As expected. The Covid-19 test is now available via their US partner via Medicare and Mediaid.
Commercial release of Covid19 risk test announced to be ready in US market before end of May.
In the meantime - watch out for a coming spike when they launch their integration towards Medicare and Medicaid for their Covid-19 risk assessment test.
If only GENE could make a gene-test that would tell if a patient will get an adverser reaction to the AstraZeneca vaccine towards Covid-19 - then they would have a winner!
Finally - getting closer to the launch of Covid-19 Risk test in the US market. See announcement today
Nice... :)
Whats up?
oversold
seems like the market in general did not get the story about the distribution agreement for USA for the Covid-19 risk test.
untill the next earning report day...
There is good news on GENE's website!
Trade is stopped by the company. News will coming...
good or bad news?
 The want  announce in relation to a material distribution agreement. So good news. See Link:https://hotcopper.com.au/threads/ann-trading-halt.5938772/
 muito obrigado..
no market today?!!!
Very good opportunity to buy...
Polygenic Covid Risk Assessment Kit is coming soon
aqms
sorry, wrong forum.. my mistake..
Jan 28th is the key date
‘The Company will provide an update on further advancements to its diagnostic tests and hold an investor webinar to discuss the quarterly update, on Thursday, January 28, 2021 at 11:30 AEDT’
 tks
cheers
Any idea if I buy again today around 5$ could it rally tomorrow or coming week?
News: https://finance.yahoo.com/news/genetic-technologies-provides-covid-19-120000548.html
https://www.globenewswire.com/news-release/2021/01/21/2162005/0/en/Genetic-Technologies-Provides-Update-on-its-COVID-19-Disease-Severity-Risk-Test-and-Expansion-into-Germline-Testing.html
Great today I can sell them
Interesting.. Where do you hear of such stocks? I'm new to trading
https://www.globenewswire.com/news-release/2021/01/21/2162005/0/en/Genetic-Technologies-Provides-Update-on-its-COVID-19-Disease-Severity-Risk-Test-and-Expansion-into-Germline-Testing.html
COVID-19 test product available
low float and on watch
$5 by the end if fe
The sudden race yesterday towards the end of the trading day (Nasdaq) was due to the annual report. GENE is a mirror stock of GTG on ASX (Australian Stock Exchange). Genetic Technologies Ltd is an Australian company.  The price of GTG on ASX is now (close to end of ASX trading day ) comparable to 4.49 USD for GENE. 1 GENE = 600 GTG,
Scrivi ciò che penhttps://www.prweb.com/releases/taliaz_announces_ce_certification_for_its_predictix_digital_ai_mental_health_solution/prweb17597212.htmsi su Genetic Technologies Ltd
Sudden race up and then a brutal drop downwards and a trade stop. What is happening?
weird
You're not alone @mr. risk, GENE has been my greatest ticker.
Was wondering - alone in here at times...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.